Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4QGF1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.667 |
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.770 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.446 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.461 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.449 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.625 |
CLV_PCSK_SKI1_1 | 189 | 193 | PF00082 | 0.658 |
DEG_APCC_DBOX_1 | 121 | 129 | PF00400 | 0.620 |
DEG_APCC_DBOX_1 | 20 | 28 | PF00400 | 0.513 |
DOC_CKS1_1 | 132 | 137 | PF01111 | 0.622 |
DOC_CYCLIN_yCln2_LP_2 | 132 | 138 | PF00134 | 0.506 |
DOC_PP1_RVXF_1 | 170 | 176 | PF00149 | 0.669 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.576 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.566 |
DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.549 |
DOC_WW_Pin1_4 | 145 | 150 | PF00397 | 0.410 |
LIG_14-3-3_CanoR_1 | 167 | 175 | PF00244 | 0.595 |
LIG_14-3-3_CanoR_1 | 47 | 51 | PF00244 | 0.540 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.631 |
LIG_BIR_III_1 | 1 | 5 | PF00653 | 0.655 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.655 |
LIG_FHA_1 | 132 | 138 | PF00498 | 0.592 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.533 |
LIG_FHA_2 | 58 | 64 | PF00498 | 0.435 |
LIG_LIR_Gen_1 | 81 | 87 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 145 | 150 | PF02991 | 0.540 |
LIG_PTB_Apo_2 | 127 | 134 | PF02174 | 0.627 |
LIG_PTB_Phospho_1 | 127 | 133 | PF10480 | 0.628 |
LIG_SH2_CRK | 133 | 137 | PF00017 | 0.478 |
LIG_SH2_NCK_1 | 28 | 32 | PF00017 | 0.602 |
LIG_SH2_STAT3 | 75 | 78 | PF00017 | 0.503 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 133 | 136 | PF00017 | 0.508 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.437 |
LIG_SUMO_SIM_anti_2 | 123 | 129 | PF11976 | 0.651 |
LIG_SUMO_SIM_anti_2 | 156 | 163 | PF11976 | 0.647 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.613 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.462 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.522 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.673 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.562 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.507 |
MOD_GSK3_1 | 42 | 49 | PF00069 | 0.599 |
MOD_N-GLC_1 | 167 | 172 | PF02516 | 0.677 |
MOD_N-GLC_1 | 42 | 47 | PF02516 | 0.602 |
MOD_NEK2_1 | 66 | 71 | PF00069 | 0.480 |
MOD_NEK2_2 | 142 | 147 | PF00069 | 0.549 |
MOD_PIKK_1 | 113 | 119 | PF00454 | 0.696 |
MOD_PIKK_1 | 66 | 72 | PF00454 | 0.576 |
MOD_PIKK_1 | 86 | 92 | PF00454 | 0.648 |
MOD_PKA_2 | 166 | 172 | PF00069 | 0.574 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.521 |
MOD_Plk_4 | 142 | 148 | PF00069 | 0.539 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.467 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.530 |
MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.545 |
MOD_ProDKin_1 | 145 | 151 | PF00069 | 0.408 |
MOD_SUMO_rev_2 | 42 | 50 | PF00179 | 0.546 |
TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.482 |
TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.499 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.605 |
TRG_ER_diArg_1 | 172 | 175 | PF00400 | 0.633 |
TRG_ER_diArg_1 | 36 | 39 | PF00400 | 0.449 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBD1 | Leptomonas seymouri | 67% | 100% |
A0A1X0NGP9 | Trypanosomatidae | 50% | 96% |
A0A3R7KHE2 | Trypanosoma rangeli | 49% | 97% |
A0A3S7WS88 | Leishmania donovani | 97% | 100% |
A4H711 | Leishmania braziliensis | 83% | 100% |
A4HVD9 | Leishmania infantum | 97% | 100% |
C9ZTQ8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 97% |
E9AP37 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |